Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy
Open Access
Abstract
(1) Background: A reliable non-invasive distinction between low- and high-risk pancreatic intraductal papillary mucinous neoplasms (IPMN) is needed to effectively detect IPMN with malignant potential. This would improve preventative care and reduce the risk of developing pancreatic cancer and overtreatment. The present study aimed at exploring the presence of autoreactive antibodies in the blood of patients with IPMN of various grades of dysplasia. (2) Methods: A single-center cohort was studied composed of 378 serum samples from patients with low-grade IPMN (n = 91), high-grade IPMN (n = 66), IPMN with associated invasive cancer (n = 30), pancreatic ductal adenocarcinoma (PDAC) stages T1 (n = 24) and T2 (n = 113), and healthy controls (n = 54). A 249 full-length recombinant human protein microarray was used for profiling the serum samples. (3) Results: 14 proteins were identified as potential biomarkers for grade distinction in IPMN, yielding high specificity but mediocre sensitivity. (4) Conclusions: The identified autoantibodies are potential biomarkers that may assist in the detection of malignancy in IPMN patients.Keywords
This publication has 56 references indexed in Scilit:
- Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsJournal of Hematology & Oncology, 2013
- A public genome-scale lentiviral expression library of human ORFsNature Methods, 2011
- Seromic profiling of ovarian and pancreatic cancerProceedings of the National Academy of Sciences, 2010
- Serum and Tissue Profiling in Bladder Cancer Combining Protein and Tissue ArraysJournal of Proteome Research, 2009
- Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein MicroarraysMolecular & Cellular Proteomics, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Identification of differentially expressed proteins in ovarian cancer using high-density protein microarraysProceedings of the National Academy of Sciences, 2007
- Generation of High Density Protein Microarrays by Cell-free in Situ Expression of Unpurified PCR ProductsMolecular & Cellular Proteomics, 2006
- Protein microarrays: catching the proteomeMechanisms of Ageing and Development, 2005
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000